ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Update

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) was the recipient of a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 9,200 shares, a growth of 5.7% from the August 31st total of 8,700 shares. Based on an average daily volume of 13,500 shares, the days-to-cover ratio is currently 0.7 days.

Institutional Trading of ProShares Ultra Nasdaq Biotechnology

A number of large investors have recently made changes to their positions in the company. Clarity Capital Partners LLC purchased a new position in shares of ProShares Ultra Nasdaq Biotechnology in the 4th quarter valued at about $201,000. Texas Capital Bank Wealth Management Services Inc acquired a new position in shares of ProShares Ultra Nasdaq Biotechnology in the first quarter worth $288,000. Westwood Wealth Management purchased a new stake in ProShares Ultra Nasdaq Biotechnology during the 1st quarter worth about $575,000. Finally, Toth Financial Advisory Corp raised its stake in ProShares Ultra Nasdaq Biotechnology by 132.3% in the 1st quarter. Toth Financial Advisory Corp now owns 26,111 shares of the exchange traded fund’s stock valued at $1,502,000 after purchasing an additional 14,870 shares during the last quarter.

ProShares Ultra Nasdaq Biotechnology Stock Up 0.9 %

ProShares Ultra Nasdaq Biotechnology stock traded up $0.57 during trading on Tuesday, hitting $63.76. The company had a trading volume of 10,721 shares, compared to its average volume of 25,440. The company’s 50 day simple moving average is $65.08 and its 200-day simple moving average is $59.71. ProShares Ultra Nasdaq Biotechnology has a 1-year low of $40.10 and a 1-year high of $69.56.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The company also recently announced a dividend, which will be paid on Wednesday, October 2nd. Investors of record on Wednesday, September 25th will be issued a $0.1528 dividend. This is a boost from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.04. The ex-dividend date of this dividend is Wednesday, September 25th.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.